Fig 8. Effect of CYP-epoxygenase inhibitor (MS-PPOH, 1 μM) on coronary reactive hyperemia (CRH) in wild type (WT) mice.
Each WT isolated mouse heart was used as its own control. (A) tracing depicting coronary flow changes at baseline (before CRH) and after CRH was induced by 15-second no-flow ischemia in WT (continuous line) and MS-PPOH-treated WT (dashed line) mice. Repayment volume (B), baseline CF (E), PHF (F), and LVDP (G) decreased (p < 0.05) in MS-PPOH-treated WT versus WT mice. Repayment/debt ratio (C) increased (p < 0.05), whereas repayment duration (D) did not change (p > 0.05) after in MS-PPOH-treated WT versus WT mice. * p < 0.05 versus WT. n = 8.